Krishan Ragab Bansal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Krishan Ragab Bansal has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
David Arnold
Respiratory Medicine, NHS North Bristol NHS Trust, Bristol, England, UK
2 shared publicationsFergus Hamilton
Academic MRC Integrative Epidemiology Unit, University of Bristol, Bristol, England, UK
2 shared publicationsNick Maskell
2 shared publicationsWilliam Cooper
Radiology Department, Southmead Hospital, Bristol, England, UK
2 shared publicationsAnna Bibby
1 shared publicationAnna Morley
Respiratory Medicine, University of Bristol Academic Respiratory Unit, Bristol, UK
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by BMJ in Emergency Medicine Journal
Corticosteroids in community-acquired pneumonia: a reflection on current guidelines and practice
- 17 September 2026
- Published by BMJ in Emergency Medicine Journal
Open AccessCorticosteroids in community-acquired pneumonia: a reflection on current guidelines and practice
- Open Access
- 28 August 2026
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 7 (8)
Community-acquired pneumonia in adults: acute and long-term complications
- 28 August 2026
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 7 (8)
Open AccessCommunity-acquired pneumonia in adults: acute and long-term complications
- 25 December 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (12) , e269865
Pericardial fat necrosis: an underdiagnosed cause of acute chest pain
Pericardial fat necrosis (PFN) is a rare, benign cause of acute pleuritic chest pain, sharing symptomatic overlap with more serious cardiopulmonary conditions. We present a case of a woman in her early 50s who experienced progressive, left-sided pleuritic chest pain. Initial investigations, including an ECG, troponin and D-dimer, were negative. On re-presentation, inflammatory markers were raised and a small left pleural effusion was noted. CT pulmonary angiography, performed to exclude pulmonary embolism, revealed focal pericardial fat inflammation, retrospectively diagnosed as PFN. Follow-up imaging demonstrated complete resolution, consistent with the self-limiting nature of the condition. This case highlights the diagnostic challenge posed by PFN, given its non-specific symptoms which often mimic more serious acute pathology. Given that many patients undergo CT imaging as part of their work-up, awareness of PFN can prevent unnecessary, and potentially invasive, further investigations.
- 25 December 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (12) , e269865
Pericardial fat necrosis: an underdiagnosed cause of acute chest pain
Pericardial fat necrosis (PFN) is a rare, benign cause of acute pleuritic chest pain, sharing symptomatic overlap with more serious cardiopulmonary conditions. We present a case of a woman in her early 50s who experienced progressive, left-sided pleuritic chest pain. Initial investigations, including an ECG, troponin and D-dimer, were negative. On re-presentation, inflammatory markers were raised and a small left pleural effusion was noted. CT pulmonary angiography, performed to exclude pulmonary embolism, revealed focal pericardial fat inflammation, retrospectively diagnosed as PFN. Follow-up imaging demonstrated complete resolution, consistent with the self-limiting nature of the condition. This case highlights the diagnostic challenge posed by PFN, given its non-specific symptoms which often mimic more serious acute pathology. Given that many patients undergo CT imaging as part of their work-up, awareness of PFN can prevent unnecessary, and potentially invasive, further investigations.
- 14 December 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (12) , e269718
Congenital vascular abnormality presenting as life-long asthma
A female in her early 40s with a lifelong asthma diagnosis presented with worsening exertional dyspnoea and a dry cough despite being medically optimised. A clinical review revealed inspiratory stridor and swallowing difficulties, prompting further investigations. Spirometry showed an obstructive pattern and an elevated Empey index. This, along with a supporting flow-volume loop, raised suspicion of upper airway obstruction. Subsequent CT imaging (including an aortic angiogram) revealed a right-sided aortic arch with an aberrant left subclavian artery arising from a Kommerrell diverticulum. This formed a vascular ring compressing the trachea and oesophagus. Surgical intervention resulted in significant symptomatic and physiological improvement, with a markedly increased FEV 1 and peak expiratory flow on repeat spirometry. This case highlights the importance of reconsidering diagnoses in patients unresponsive to standard therapy and the diagnostic utility of the Empey Index and flow-volume loops when identifying conditions mimicking asthma.
- 14 December 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (12) , e269718
Congenital vascular abnormality presenting as life-long asthma
A female in her early 40s with a lifelong asthma diagnosis presented with worsening exertional dyspnoea and a dry cough despite being medically optimised. A clinical review revealed inspiratory stridor and swallowing difficulties, prompting further investigations. Spirometry showed an obstructive pattern and an elevated Empey index. This, along with a supporting flow-volume loop, raised suspicion of upper airway obstruction. Subsequent CT imaging (including an aortic angiogram) revealed a right-sided aortic arch with an aberrant left subclavian artery arising from a Kommerrell diverticulum. This formed a vascular ring compressing the trachea and oesophagus. Surgical intervention resulted in significant symptomatic and physiological improvement, with a markedly increased FEV 1 and peak expiratory flow on repeat spirometry. This case highlights the importance of reconsidering diagnoses in patients unresponsive to standard therapy and the diagnostic utility of the Empey Index and flow-volume loops when identifying conditions mimicking asthma.
- Open Access
- 10 December 2025
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 12 (1) , e003675
First-line medical thoracoscopy for pleural infection: the SPIRIT randomised controlled feasibility trial
Background: Pleural infection remains a significant clinical challenge, requiring hospitalisation, intravenous antibiotics and early chest drain insertion. Medical thoracoscopy (MT), a minimally invasive procedure used electively in the UK for malignant effusions, has demonstrated good outcomes when applied to acute pleural infection in retrospective case series. However, it has not been evaluated as a first-line intervention in the UK in a randomised controlled trial (RCT). Objectives: The Studying Pleuroscopy in Routine Pleural Infection Treatment (SPIRIT) trial assessed the feasibility of conducting a full-scale RCT comparing MT with chest drain insertion for acute pleural infection within UK National Health Service (NHS) hospitals. Methods: SPIRIT was an open-label, randomised feasibility trial conducted across seven NHS centres between 2017 and 2019. Adults with suspected pleural infection were prescreened; eligible patients were randomised to either chest drain insertion (control) or MT (performed the same or following day) with 90-day follow-up. The primary outcome was feasibility, assessed through a composite of prescreen, screen and allocation failure rates. Secondary outcomes included inpatient-stay duration, mortality, radiological and microbiological outcomes, second-line interventions, patient-reported outcomes and adverse events. Results: Of 193 patients prescreened, 181 (93.8%) were excluded due to at least one criterion. Key factors included lack of MT deliverability (49.2%), a not truly infected effusion (45.1%) and contraindications to drainage or study involvement (44.0%). Consequently, the primary feasibility endpoint was not met. All 12 eligible patients were randomised with no attrition. MT lasted 15 min longer than drain insertion, but chest drains remained in situ over 3 days longer (p=0.17) with a longer hospital stay (p=0.57). Radiological improvement, microbiological yield and symptom scores were similar. Adverse events occurred in one control and three MT patients. Conclusion: A full-scale RCT is not likely to be feasible in an NHS setting on the proposed protocol. Targeted recruitment from centres equipped for emergency MT may enhance feasibility. Trial registration number: ISRCTN98460319 .
- 10 December 2025
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 12 (1) , e003675
Open AccessFirst-line medical thoracoscopy for pleural infection: the SPIRIT randomised controlled feasibility trial
Background: Pleural infection remains a significant clinical challenge, requiring hospitalisation, intravenous antibiotics and early chest drain insertion. Medical thoracoscopy (MT), a minimally invasive procedure used electively in the UK for malignant effusions, has demonstrated good outcomes when applied to acute pleural infection in retrospective case series. However, it has not been evaluated as a first-line intervention in the UK in a randomised controlled trial (RCT). Objectives: The Studying Pleuroscopy in Routine Pleural Infection Treatment (SPIRIT) trial assessed the feasibility of conducting a full-scale RCT comparing MT with chest drain insertion for acute pleural infection within UK National Health Service (NHS) hospitals. Methods: SPIRIT was an open-label, randomised feasibility trial conducted across seven NHS centres between 2017 and 2019. Adults with suspected pleural infection were prescreened; eligible patients were randomised to either chest drain insertion (control) or MT (performed the same or following day) with 90-day follow-up. The primary outcome was feasibility, assessed through a composite of prescreen, screen and allocation failure rates. Secondary outcomes included inpatient-stay duration, mortality, radiological and microbiological outcomes, second-line interventions, patient-reported outcomes and adverse events. Results: Of 193 patients prescreened, 181 (93.8%) were excluded due to at least one criterion. Key factors included lack of MT deliverability (49.2%), a not truly infected effusion (45.1%) and contraindications to drainage or study involvement (44.0%). Consequently, the primary feasibility endpoint was not met. All 12 eligible patients were randomised with no attrition. MT lasted 15 min longer than drain insertion, but chest drains remained in situ over 3 days longer (p=0.17) with a longer hospital stay (p=0.57). Radiological improvement, microbiological yield and symptom scores were similar. Adverse events occurred in one control and three MT patients. Conclusion: A full-scale RCT is not likely to be feasible in an NHS setting on the proposed protocol. Targeted recruitment from centres equipped for emergency MT may enhance feasibility. Trial registration number: ISRCTN98460319 .
- Open Access
- 1 January 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (6) , 683
Reducing the complications from community acquired pneumonia: a review
Community-acquired pneumonia (CAP) represents a major healthcare burden worldwide, associated with significant morbidity and mortality. Management of the acute infection centres around the administration of antibiotic therapy alongside other supportive measures, particularly in those with sepsis. This includes fluid resuscitation, supplemental oxygen and intensive care admission in severe cases. This forms the mainstay of clinical practice and falls outside the scope of this review. There is a growing understanding in the literature that CAP is associated with complications extending well beyond the initial infectious episode. Increased cardiovascular risk, functional decline related to sarcopenia, disease recurrence and persistent symptomology prompting healthcare re-engagement have become increasingly recognised, however there is much less consensus on their management. This review will focus on the current literature regarding interventions aimed at mitigating these longer-term complications. Specifically, we evaluate evidence on the use of antiplatelet, cholesterol-lowering and anticoagulant therapies for cardiovascular risk reduction, physical therapy rehabilitation for functional recovery, adjunctive macrolide therapy for immunomodulatory benefit and optimising discharge planning to reduce healthcare reconsultation. This review aims to appraise the existing evidence base for each intervention, identifying opportunities to refine post-CAP care to inform future longitudinal research and develop clinical practice.
- 1 January 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (6) , 683
Open AccessReducing the complications from community acquired pneumonia: a review
Community-acquired pneumonia (CAP) represents a major healthcare burden worldwide, associated with significant morbidity and mortality. Management of the acute infection centres around the administration of antibiotic therapy alongside other supportive measures, particularly in those with sepsis. This includes fluid resuscitation, supplemental oxygen and intensive care admission in severe cases. This forms the mainstay of clinical practice and falls outside the scope of this review. There is a growing understanding in the literature that CAP is associated with complications extending well beyond the initial infectious episode. Increased cardiovascular risk, functional decline related to sarcopenia, disease recurrence and persistent symptomology prompting healthcare re-engagement have become increasingly recognised, however there is much less consensus on their management. This review will focus on the current literature regarding interventions aimed at mitigating these longer-term complications. Specifically, we evaluate evidence on the use of antiplatelet, cholesterol-lowering and anticoagulant therapies for cardiovascular risk reduction, physical therapy rehabilitation for functional recovery, adjunctive macrolide therapy for immunomodulatory benefit and optimising discharge planning to reduce healthcare reconsultation. This review aims to appraise the existing evidence base for each intervention, identifying opportunities to refine post-CAP care to inform future longitudinal research and develop clinical practice.